The global inhalation anaesthesia market size reached a value of more than USD 1.14 billion in 2023. The market is further estimated to grow at a CAGR of 9.40% in the forecast period of 2024-2032.
Based on drug type, the increasing utilisation of sevoflurane is supporting the market growth of inhalation anaesthesia. Sevoflurane is being increasingly administered due to its several benefits like pleasant odour, rapid induction, reduced incidences of postoperative nausea, and minimal cardiac toxicity, among others.
There is a rising inclination towards using sevoflurane in patients with difficult airways or severe bronchospastic disease, who require mask induction, as it results in lesser irritation to mucous membranes. The drug also provides rapid recovery, and the patients are more conscious in the recovery period when compared to other drugs, like halothane or isoflurane.
Sevoflurane possesses an excellent safety record and is administered to adults and the paediatric age group for inpatient and outpatient surgery. Further, the increasing approvals of sevoflurane by health bodies, such as the U.S. Food and Drug Administration, for the induction and maintenance of anaesthesia during surgical and procedural interventions is likely to stimulate the inhalation anaesthesia market development in the forecast period.
Inhalation anaesthesia is the process of delivering anaesthesia through inhalation using drugs like sevoflurane, desflurane, and isoflurane during a surgical procedure. It is administered through a face mask or tracheal tube connected to an anaesthetic vaporiser.
The market for inhalation anaesthesia, by drug type, is divided into:
Based on application, the market is classified into:
The regional markets for inhalation anaesthesia can be divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The increasing demand for surgical procedures worldwide due to the growing prevalence of chronic diseases and rising applications of inhalation anaesthesia for the induction and maintenance of general anaesthesia and sedation are contributing to the market expansion. Inhalation anaesthesia eliminates the issues of dose calculation and variations as compared to injectable agents. Also, it allows the convenient adjustment of anaesthetic depth and enables positive pressure ventilation when necessary.
As inhalation anaesthesia offers multiple advantages such as enhanced safety, feasibility, and customisability as compared to intravenous anaesthesia, its preference is surging. In addition, the rising availability of different drugs, like sevoflurane, desflurane, and isoflurane, among others, is adding on to the inhalation anaesthesia market demand. The developing healthcare infrastructure and the expanding geriatric population are also providing impetus to the market development of inhalation anaesthesia.
Various efforts taken by governments across the globe to approve drugs for the healthcare sector are playing a critical role in the market growth of inhalation anaesthesia. The strong presence of market players and their favourable initiatives to launch drugs that help patients gain access to cost-effective and advanced health treatments are expected to augment the market over the forecast period.
The report gives a detailed analysis of the following key players in the global inhalation anaesthesia market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
|Scope of the Report||
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|Breakup by Drug Type||
|Breakup by Application||
|Breakup by Region||
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Market Snapshot
7 Industry Opportunities and Challenges
8 Global Inhalation Anaesthesia Market Analysis
8.1 Key Industry Highlights
8.2 Global Inhalation Anaesthesia Historical Market (2018-2023)
8.3 Global Inhalation Anaesthesia Market Forecast (2024-2032)
8.4 Global Inhalation Anaesthesia Market by Drug Type
22.214.171.124 Market Share
126.96.36.199 Historical Trend (2018-2023)
188.8.131.52 Forecast Trend (2024-2032)
184.108.40.206 Market Share
220.127.116.11 Historical Trend (2018-2023)
18.104.22.168 Forecast Trend (2024-2032)
22.214.171.124 Market Share
126.96.36.199 Historical Trend (2018-2023)
188.8.131.52 Forecast Trend (2024-2032)
184.108.40.206 Market Share
220.127.116.11 Historical Trend (2018-2023)
18.104.22.168 Forecast Trend (2024-2032)
8.5 Global Inhalation Anaesthesia Market by Application
22.214.171.124 Market Share
126.96.36.199 Historical Trend (2018-2023)
188.8.131.52 Forecast Trend (2024-2032)
184.108.40.206 Market Share
220.127.116.11 Historical Trend (2018-2023)
18.104.22.168 Forecast Trend (2024-2032)
8.6 Global Inhalation Anaesthesia Market by Region
8.6.1 Market Share
22.214.171.124 North America
126.96.36.199 Asia Pacific
188.8.131.52 Latin America
184.108.40.206 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2018-2023)
9.1.2 Forecast Trend (2024-2032)
9.1.3 Breakup by Country
220.127.116.11 United States of America
9.2.1 Historical Trend (2018-2023)
9.2.2 Forecast Trend (2024-2032)
9.2.3 Breakup by Country
18.104.22.168 United Kingdom
9.3 Asia Pacific
9.3.1 Historical Trend (2018-2023)
9.3.2 Forecast Trend (2024-2032)
9.3.3 Breakup by Country
9.4 Latin America
9.4.1 Historical Trend (2018-2023)
9.4.2 Forecast Trend (2024-2032)
9.4.3 Breakup by Country
9.5 Middle East and Africa
9.5.1 Historical Trend (2018-2023)
9.5.2 Forecast Trend (2024-2032)
9.5.3 Breakup by Country
22.214.171.124 Saudi Arabia
126.96.36.199 United Arab Emirates
188.8.131.52 South Africa
10 Market Dynamics
10.1 SWOT Analysis
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Competitive Landscape
11.1 Market Structure
11.2 Company Profiles
11.2.1 Halocarbon Life Sciences, LLC.
184.108.40.206 Company Overview
220.127.116.11 Product Portfolio
18.104.22.168 Demographic Reach and Achievements
11.2.2 Baxter International Inc
22.214.171.124 Company Overview
126.96.36.199 Product Portfolio
188.8.131.52 Demographic Reach and Achievements
11.2.3 AbbVie Inc.
184.108.40.206 Company Overview
220.127.116.11 Product Portfolio
18.104.22.168 Demographic Reach and Achievements
11.2.4 Sandoz AG
22.214.171.124 Company Overview
126.96.36.199 Product Portfolio
188.8.131.52 Demographic Reach and Achievements
11.2.5 Piramal Enterprises Ltd.
184.108.40.206 Company Overview
220.127.116.11 Product Portfolio
18.104.22.168 Demographic Reach and Achievements
12 Industry Events and Developments
List of Key Figures and Tables
1. Global Inhalation Anaesthesia Market: Key Industry Highlights, 2018 and 2032
2. Global Inhalation Anaesthesia Historical Market: Breakup by Drug Type (USD Billion), 2018-2023
3. Global Inhalation Anaesthesia Market Forecast: Breakup by Drug Type (USD Billion), 2024-2032
4. Global Inhalation Anaesthesia Historical Market: Breakup by Application (USD Billion), 2018-2023
5. Global Inhalation Anaesthesia Market Forecast: Breakup by Application (USD Billion), 2024-2032
6. Global Inhalation Anaesthesia Historical Market: Breakup by Region (USD Billion), 2018-2023
7. Global Inhalation Anaesthesia Market Forecast: Breakup by Region (USD Billion), 2024-2032
8. North America Inhalation Anaesthesia Historical Market: Breakup by Country (USD Billion), 2018-2023
9. North America Inhalation Anaesthesia Market Forecast: Breakup by Country (USD Billion), 2024-2032
10. Europe Inhalation Anaesthesia Historical Market: Breakup by Country (USD Billion), 2018-2023
11. Europe Inhalation Anaesthesia Market Forecast: Breakup by Country (USD Billion), 2024-2032
12. Asia Pacific Inhalation Anaesthesia Historical Market: Breakup by Country (USD Billion), 2018-2023
13. Asia Pacific Inhalation Anaesthesia Market Forecast: Breakup by Country (USD Billion), 2024-2032
14. Latin America Inhalation Anaesthesia Historical Market: Breakup by Country (USD Billion), 2018-2023
15. Latin America Inhalation Anaesthesia Market Forecast: Breakup by Country (USD Billion), 2024-2032
16. Middle East and Africa Inhalation Anaesthesia Historical Market: Breakup by Country (USD Billion), 2018-2023
17. Middle East and Africa Inhalation Anaesthesia Market Forecast: Breakup by Country (USD Billion), 2024-2032
18. Global Inhalation Anaesthesia Market Structure.
In 2023, the market attained a value of over USD 1.14 billion.
The market is assessed to grow at a CAGR of 9.40% between 2024 and 2032.
The major market drivers include the multiple advantages offered by inhalation anaesthesia, developing healthcare infrastructure, the rising availability of different drugs, expanding geriatric population, and the increasing demand for sevoflurane.
The key market trends guiding the growth of the market include the increasing number of surgical procedures worldwide, the surging government approvals of new drugs, the strong presence of market players, and new drug launches by leading market players.
Isoflurane is considered the most potent inhalation anaesthesia drug and is used as a volatile anaesthetics in clinical applications.
The major regions in the inhalation anaesthesia market are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
The significant drug types of inhalation anaesthesia, include sevoflurane, desflurane, isoflurane, and halothane.
The various applications of inhalation anaesthesia include induction and maintenance.
Inhalation anaesthesia is rapidly adjustable, precise, and safe, which is increasing its preference for delivering anaesthesia. Moreover, potent anaesthesia drugs are increasingly used for prolonged sedation during mechanical ventilation owing to their advantageous respiratory efforts, dose-dependent muscle relaxation, and effective sedative effects, among others.
The major players in the market are Halocarbon Life Sciences, LLC., Baxter International Inc, AbbVie Inc., Sandoz AG, and Piramal Enterprises Ltd., among others.
Single User License
Five User License
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.